Walgreens Boots Alliance Stock (NASDAQ:WBA)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$8.29

52W Range

$8.11 - $27.05

50D Avg

$9.17

200D Avg

$14.27

Market Cap

$7.12B

Avg Vol (3M)

$22.33M

Beta

0.67

Div Yield

$1.00 (15.17%)

WBA Company Profile


Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Show More

Industry

Medical - Pharmaceuticals

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

193,000

IPO Date

Mar 17, 1980

Website

WBA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceAug 24Aug 23Aug 22
International Reportable Segment$23.55B$22.20B$21.83B
Retail Pharmacy USA$115.78B$110.31B-
Walgreens Health--$1.79B

Fiscal year ends in Aug 24 | Currency in USD

WBA Financial Summary


Aug 24Aug 23Aug 22
Revenue$268.79B$139.08B$132.70B
Operating Income$-1.59B$-6.88B$4.38B
Net Income$-8.64B$-3.08B$4.34B
EBITDA$-1.59B$-2.58B$6.38B
Basic EPS$-10.01$-3.57$5.02
Diluted EPS$-10.01$-3.57$5.01

Fiscal year ends in Aug 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Oct 15, 24 | 12:38 PM
Q3 24Jun 27, 24 | 12:27 PM
Q2 24Mar 28, 24 | 12:38 PM

Peer Comparison


TickerCompany
MDVLMedAvail Holdings, Inc.
PETSPetMed Express, Inc.
BIMIBIMI International Medical Inc.
LFLYLeafly Holdings, Inc.
CJJDChina Jo-Jo Drugstores, Inc.
HITIHigh Tide Inc.
YI111, Inc.
RADRite Aid Corporation
MEDSScienture Holdings, Inc.